CGMBF(CGMBF)
CGMBF
No analyst ratings available
No analyst price targets available for CGMBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $148.52B | $157.68B | $167.95B |
| Low | $145.93B | $155.11B | $165.12B |
| High | $151.77B | $164.06B | $173.21B |
| EBITDA Avg | $46.22B | $48.55B | $53.44B |
| Low | $45.38B | $47.64B | $52.42B |
| High | $47.78B | $50.22B | $55.33B |
| EBIT Avg | $38.37B | $41.24B | $46.50B |
| Low | $37.52B | $40.33B | $45.48B |
| High | $39.93B | $42.91B | $48.39B |
| Net Income Avg | $30.31B | $32.58B | $36.73B |
| Low | $29.64B | $31.86B | $35.93B |
| High | $31.54B | $33.90B | $38.23B |
| EPS Avg | $0.66 | $0.71 | $0.80 |
| Low | $0.65 | $0.69 | $0.78 |
| High | $0.69 | $0.74 | $0.83 |
| Analysts (Rev / EPS) | 5 / 1 | 4 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| Low | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| High | $62.37B | $61.66B | $60.95B | $60.25B | $59.56B |
| EBITDA Avg | $17.06B | $31.79B | $19.22B | $33.55B | $20.26B |
| Low | $17.06B | $31.79B | $19.22B | $33.55B | $20.26B |
| High | $17.06B | $31.79B | $19.22B | $33.55B | $20.26B |
| EBIT Avg | $14.35B | $29.12B | $16.58B | $30.95B | $17.69B |
| Low | $14.35B | $29.12B | $16.58B | $30.95B | $17.69B |
| High | $14.35B | $29.12B | $16.58B | $30.95B | $17.69B |
| Net Income Avg | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| Low | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| High | $11.34B | $23.00B | $13.10B | $24.45B | $13.97B |
| EPS Avg | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| Low | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| High | $0.26 | $0.52 | $0.30 | $0.55 | $0.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |